window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : September 19, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Genomics and sequencing

  • Genomics and sequencing,Manufacturing & Supply Chain,Research & Development

    DNA Script and GE HealthCare awarded up to $26M for DNA bioproduction programme

    DNA Script and GE HealthCare are developing an automated platform [...]

    August 4, 2026
  • Clinical & Regulatory,Drug Discovery & Development,Genomics and sequencing,Pharmaceuticals and therapeutics,Research & Development,Therapeutic Areas

    Medicus Pharma gets UAE approval to start genomics-guided endometriosis study

    Medicus Pharma has received authorisation from the UAE Department of [...]

    July 31, 2026
  • Genomics and sequencing,Research & Development

    Novogene expands single-cell sequencing capability in Cambridge

    Novogene Europe has expanded its single-cell RNA sequencing capability at [...]

    July 27, 2026
  • Advanced Therapies,Clinical & Regulatory,Genomics and sequencing,Pharmaceuticals and therapeutics,Research & Development

    Atsena receives EMA orphan designation for two inherited retinal disease gene therapies

    Atsena Therapeutics has received EMA orphan designation for two gene [...]

    July 24, 2026
  • Clinical & Regulatory,Digital & Data,Genomics and sequencing,Research & Development

    Seegene launches global study to evaluate comprehensive PCR testing for respiratory infections

    Seegene has launched the Global Million Clinical Study (GMCS), an [...]

    July 16, 2026
  • Drug Discovery & Development,Genomics and sequencing,Research & Development

    Nucleome strengthens 3D genomics platform with US patent for Micro Capture-C technology

    Nucleome Therapeutics has strengthened its intellectual property portfolio after the [...]

    July 14, 2026
  • Drug Discovery & Development,Genomics and sequencing,Research & Development

    Novogene expands Cambridge Omics Centre with untargeted metabolomics service

    Novogene Europe has expanded its Cambridge Omics Centre with the [...]

    July 14, 2026
  • Clinical & Regulatory,Digital & Data,Genomics and sequencing

    Quest Diagnostics expands access to molecular cancer testing through OncoEMR

    Quest Diagnostics has integrated its Haystack MRD test and comprehensive [...]

    July 9, 2026
  • Advanced Therapies,Genomics and sequencing,Research & Development,Therapeutic Areas

    Genespire reports preclinical gene therapy data for methylmalonic acidemia

    Genespire and researchers at the San Raffaele Telethon Institute for [...]

    July 8, 2026
  • Biotech & Pharma Business,Drug Discovery & Development,Genomics and sequencing,Research & Development

    Evogene advances ChemPass AI milestone in Google Cloud collaboration for autonomous small molecule discovery

    Evogene reports a major Google Cloud collaboration milestone advancing agentic [...]

    June 25, 2026
Previous123Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Resolution Therapeutics partners with Blood Centers of America for RTX001 programme
    Categories: Advanced Therapies, Biotech & Pharma Business, Clinical & Regulatory, Pharmaceuticals and therapeutics
  • Researchers develop human iPS cell model of heart failure
    Categories: Drug Discovery & Development, Pharmaceuticals and therapeutics, Research & Development, Therapeutic Areas
  • Resolution Therapeutics completes Phase 1/2 RTX001 liver disease trial dosing
    Categories: Advanced Therapies, Clinical & Regulatory, Pharmaceuticals and therapeutics, Research & Development, Therapeutic Areas
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details.
OK
Go to Top